Indicators

Latest News about INCY

Recent news which mentions INCY

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Goldman Sachs Maintains Buy Rating for Incyte: Here's What You Need To Know

November 02, 2023

Earnings Outlook For Incyte

October 30, 2023

Quant Ratings Updated on 73 Stocks

September 26, 2023

Expert Ratings for Incyte

September 21, 2023

3 Biotech Stocks That Should Be on Every Investor’s Radar This Fall

September 20, 2023

Anemia Advantage For GSK's Blood Cancer Therapy Could Influence Market Share Despite Incyte's Jakafi Comparison

September 18, 2023

Analyst Ratings for Incyte

August 02, 2023

Incyte's Jakafi Patent Expiry In 2028 Poses Challenge, Analyst Says New Treatments To Battle For Market Share

August 01, 2023

Incyte's Earnings Outlook

July 31, 2023

Cathie Wood's Ark Invest Buys Spotify, Iridium Shares — Trims Tesla, Coinbase Holdings

July 25, 2023

Benzinga's Top Ratings Upgrades, Downgrades For July 25, 2023

July 25, 2023

Syndax-Incyte Partnered Chronic Graft-Versus-Host Disease Achieves Primary Endpoint In Pivotal Trial, FDA Submission Planned By 2023 End

July 24, 2023

'I Don't Want You To Touch That': Cramer Rejects Stock Down 32% Over Past Month, Prefers Tesla

July 19, 2023

Incyte Skin Disease Drug Meets Primary Goal In Late-Stage Study In Children

July 12, 2023

Syndax Pharmaceuticals Set for Potential Breakthrough with Revumenib: Analyst Calls It 'Potentially Best-In-Class' In Competitive Landscape

July 11, 2023

2 Low-Priced Stocks That Could Make You Richer

June 26, 2023

The bull market has left these 20 companies behind, but they are primed for growth

June 13, 2023

Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2023

May 04, 2023

Why Incyte Shares Are Falling Today

May 02, 2023

Earnings Outlook For Incyte

May 01, 2023

What To Expect When Incyte Reports Q1 Earnings In Almost Two Weeks

April 21, 2023

7 Biotech Stocks That Could Cure Your Portfolio Woes

April 19, 2023

Ominous Death Cross Forms On Incyte's Chart

April 13, 2023

Incyte Faces Increased Competition From Emerging JAK Inhibitors, RBC Capital Lowers Price Target

April 10, 2023

Benzinga's Top Ratings Upgrades, Downgrades For April 10, 2023

April 10, 2023

Valero Energy To Rally 32%? Here Are 10 Other Analyst Forecasts For Monday

April 10, 2023

What 13 Analyst Ratings Have To Say About Incyte

March 28, 2023

Second Setback For Incyte's LIMBER Program - Analyst Says 'Resolution Timelines Unclear To Assess Impact'

March 24, 2023

Incyte Would Now Compete With Merck, Pfizer As Its Skin Cancer Treatment Scores FDA Accelerated Approval

March 23, 2023

7 Healthcare Stocks to Buy for Long-Term Growth and Stability

March 21, 2023

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.